About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

The University of Minnesota and Essentia said in January they were in early discussions to form a nonprofit entity.

NEW HAVEN, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company ...

In conjunction with (i) the royalty financing deal with HealthCare Royalty (HCRx) announced on January 30, 2025, and (ii) the final terms of the dual proposal to the 2025 OCEANEs holders announced on ...

Collaboration will combine AbbVie's oncology expertise and Xilio's proprietary tumor-activation technology to develop novel immunotherapies, including masked T-cell ...

Texas Attorney General Ken Paxton is seeking broad access to patient medical records as he battles a Dallas doctor under the ...

The medical use of artificial intelligence (AI) threatens to undermine patients' ability to make personalized decisions. New ...

The Albany Med Health System and CDPHP announced last week the organizations have agreed on a new two-year contract which ...

Excessive waiting for appointments, for treatments to begin and for phone calls to be returned; a lack of coordination among ...

Allina Health System and other health care providers escaped a suit accusing them of sharing swaths of patients’ sensitive data without consent with third parties including Meta Platforms Inc.

Advisers representing lenders to WW International, the health and wellness company known as WeightWatchers, have signed a ...